# A Safety and Cognitive Function Study of EVP-6124 Versus Placebo in Subjects With Nicotine Dependence

> **NCT01480232** · PHASE2 · TERMINATED · sponsor: **A. Eden Evins** · enrollment: 345 (actual)

## Conditions studied

- Nicotine Dependence
- Smoking Cessation

## Interventions

- **DRUG:** EVP-6124
- **DRUG:** Placebo Capsule
- **DRUG:** NicoDerm Patch (Active)
- **DRUG:** NRT Patch (Placebo)
- **BEHAVIORAL:** Brief Supportive and Behavioral Treatment

## Key facts

- **NCT ID:** NCT01480232
- **Lead sponsor:** A. Eden Evins
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-12
- **Primary completion:** 2015-09
- **Final completion:** 2015-09
- **Target enrollment:** 345 (ACTUAL)
- **Why stopped:** Study has been put on clinical hold by FDA
- **Last updated:** 2017-04-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01480232

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01480232, "A Safety and Cognitive Function Study of EVP-6124 Versus Placebo in Subjects With Nicotine Dependence". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01480232. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*